{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:07:50Z","timestamp":1790356070366,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"HEALTH SCIENCE CENTER","award":["GENERAL FOUNDATION"],"award-info":[{"award-number":["GENERAL FOUNDATION"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10147-026-03128-6","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T15:03:15Z","timestamp":1787324595000},"page":"2234-2242","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Stage-dependent differences of long-term outcomes between chemoradiotherapy and surgery for squamous cell carcinoma of the anal canal: a multicenter retrospective cohort study"],"prefix":"10.1007","volume":"31","author":[{"given":"Norihiro","family":"Shimoike","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7210-7075","authenticated-orcid":false,"given":"Koya","family":"Hida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Obama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Sugihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"issue":"7","key":"3128_CR1","doi-asserted-by":"publisher","first-page":"852","DOI":"10.6004\/jnccn.2018.0060","volume":"16","author":"AB Benson","year":"2018","unstructured":"Benson AB, Venook AP, Al-Hawary MM et al (2018) Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 16(7):852\u2013871","journal-title":"J Natl Compr Canc Netw"},{"key":"3128_CR2","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.annonc.2021.06.015","volume":"32","author":"S Rao","year":"2021","unstructured":"Rao S, Guren MG, Khan K et al (2021) Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 32:1087\u20131100","journal-title":"Ann Oncol"},{"issue":"3","key":"3128_CR3","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/BF02586980","volume":"17","author":"ND Nigro","year":"1974","unstructured":"Nigro ND, Vaitkevicius VK, Considine B (1974) Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 17(3):354\u2013356","journal-title":"Dis Colon Rectum"},{"issue":"16","key":"3128_CR4","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1200\/JCO.2011.35.4837","volume":"30","author":"D Peiffert","year":"2012","unstructured":"Peiffert D, Tournier-Rangeard L, G\u00e9rard JP et al (2012) Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial. J Clin Oncol 30(16):1941\u20131948","journal-title":"J Clin Oncol"},{"issue":"9034","key":"3128_CR5","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0140-6736(96)03409-5","volume":"348","author":"UKCCCR Anal Cancer Trial Working Party","year":"1996","unstructured":"UKCCCR Anal Cancer Trial Working Party (1996) Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UK Co-ordinating Committee on Cancer Research. Lancet 348(9034):1049\u20131054","journal-title":"Lancet"},{"issue":"16","key":"3128_CR6","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","volume":"299","author":"JA Ajani","year":"2008","unstructured":"Ajani JA, Winter KA, Gunderson LL et al (2008) Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA 299(16):1914\u20131921","journal-title":"JAMA"},{"issue":"5","key":"3128_CR7","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"H Bartelink","year":"1997","unstructured":"Bartelink H, Roelofsen F, Eschwege F et al (1997) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15(5):2040\u20132049","journal-title":"J Clin Oncol"},{"issue":"7","key":"3128_CR8","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/sj.bjc.6605605","volume":"102","author":"J Northover","year":"2010","unstructured":"Northover J, Glynne-Jones R, Sebag-Montefiore D et al (2010) Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I). Br J Cancer 102(7):1123\u20131128","journal-title":"Br J Cancer"},{"issue":"1","key":"3128_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s10350-004-0746-1","volume":"48","author":"L Ghouti","year":"2005","unstructured":"Ghouti L, Houvenaeghel G, Moutardier V et al (2005) Salvage abdominoperineal resection after failure of conservative treatment in anal epidermoid cancer. Dis Colon Rectum 48(1):16\u201322","journal-title":"Dis Colon Rectum"},{"issue":"10","key":"3128_CR10","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1245\/s10434-007-9491-8","volume":"14","author":"DE Schiller","year":"2007","unstructured":"Schiller DE, Cummings BJ, Rai S et al (2007) Outcomes of salvage surgery for squamous cell carcinoma of the anal canal. Ann Surg Oncol 14(10):2780\u20132789","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"3128_CR11","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1046\/j.1365-2168.2002.02231.x","volume":"89","author":"PJ Nilsson","year":"2002","unstructured":"Nilsson PJ, Svensson C, Goldman S et al (2002) Salvage abdominoperineal resection in anal epidermoid cancer. Br J Surg 89(11):1425\u20131429","journal-title":"Br J Surg"},{"issue":"10","key":"3128_CR12","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s10350-008-9361-x","volume":"51","author":"P Mariani","year":"2008","unstructured":"Mariani P, Ghanneme A, De la Rochefordi\u00e8re A et al (2008) Abdominoperineal resection for anal cancer. Dis Colon Rectum 51(10):1495\u20131501","journal-title":"Dis Colon Rectum"},{"issue":"11","key":"3128_CR13","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1056\/NEJM200003163421107","volume":"342","author":"DP Ryan","year":"2000","unstructured":"Ryan DP, Compton CC, Mayer RJ (2000) Carcinoma of the anal canal. N Engl J Med 342(11):792\u2013800","journal-title":"N Engl J Med"},{"issue":"7","key":"3128_CR14","doi-asserted-by":"publisher","first-page":"855","DOI":"10.6004\/jnccn.2019.0033","volume":"17","author":"JA Ajani","year":"2019","unstructured":"Ajani JA, D\u2019Amico TA, Bentrem DJ et al (2019) Esophageal and esophagogastric junction cancers, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 17(7):855\u2013883","journal-title":"J Natl Compr Canc Netw"},{"issue":"suppl 5","key":"3128_CR15","doi-asserted-by":"publisher","first-page":"v50","DOI":"10.1093\/annonc\/mdw329","volume":"27","author":"F Lordick","year":"2016","unstructured":"Lordick F, Mariette C, Haustermans K et al (2016) Oesophageal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 27(suppl 5):v50\u2013v57","journal-title":"Ann Oncol"},{"issue":"14","key":"3128_CR16","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1002\/cam4.4631","volume":"11","author":"K Yamada","year":"2022","unstructured":"Yamada K, Saiki Y, Komori K et al (2022) Characteristics of anal canal cancer in Japan. Cancer Med 11(14):2735\u20132743","journal-title":"Cancer Med"},{"key":"3128_CR17","volume-title":"TNM classification of malignant tumours","author":"JD Brierley","year":"2017","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C (2017) TNM classification of malignant tumours, 8th edn. Wiley, New York","edition":"8"},{"issue":"3","key":"3128_CR18","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1214\/aos\/1176350951","volume":"16","author":"RJ Gray","year":"1988","unstructured":"Gray RJ (1988) A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16(3):1141\u20131154","journal-title":"Ann Stat"},{"issue":"24","key":"3128_CR19","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.1200\/JCO.2007.12.9866","volume":"26","author":"JJ Dignam","year":"2008","unstructured":"Dignam JJ, Kocherginsky MN (2008) Choice and interpretation of statistical tests used when competing risks are present. J Clin Oncol 26(24):4027\u20134034","journal-title":"J Clin Oncol"},{"issue":"1","key":"3128_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00031305.2019.1583913","volume":"73","author":"RL Wasserstein","year":"2019","unstructured":"Wasserstein RL, Schirm AL, Lazar NA (2019) Moving to a world beyond \u201cp < 0.05.\u201d Am Statist 73(1):1\u201319","journal-title":"Am Statist"},{"issue":"3","key":"3128_CR21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1001\/jamasurg.2017.3151","volume":"153","author":"CY Chai","year":"2018","unstructured":"Chai CY, Tran Cao HS, Awad S et al (2018) Management of stage I squamous cell carcinoma of the anal canal. JAMA Surg 153(3):209\u2013215","journal-title":"JAMA Surg"},{"issue":"3","key":"3128_CR22","doi-asserted-by":"publisher","first-page":"355","DOI":"10.6004\/jnccn.2017.0035","volume":"15","author":"AJ Kole","year":"2017","unstructured":"Kole AJ, Stahl JM, Park HS et al (2017) Predictors of nonadherence to NCCN guideline recommendations for the management of stage I anal canal cancer. J Natl Compr Canc Netw 15(3):355\u2013362","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"3128_CR23","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.ijrobp.2011.02.010","volume":"82","author":"C Ortholan","year":"2012","unstructured":"Ortholan C, Resbeut M, Hannoun-Levi JM et al (2012) Anal canal cancer: management of inguinal nodes and benefit of prophylactic inguinal irradiation (CORS-03 study). Int J Radiat Oncol Biol Phys 82(5):1988\u20131995","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"3128_CR24","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/j.1365-2559.1990.tb01159.x","volume":"16","author":"NA Shepherd","year":"1990","unstructured":"Shepherd NA, Scholefield JH, Love SB et al (1990) Prognostic factors in anal squamous carcinoma: a multivariate analysis of clinical, pathological and flow cytometric parameters in 235 cases. Histopathology 16(6):545\u2013555","journal-title":"Histopathology"},{"key":"3128_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jss.2020.05.034","volume":"255","author":"ACH Lin","year":"2020","unstructured":"Lin ACH, Hakim A, Kellish AS et al (2020) Inguinal lymph node dissection does not improve overall survival in anal cancer nodal disease. J Surg Res 255:13\u201322","journal-title":"J Surg Res"},{"issue":"10","key":"3128_CR26","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1097\/DCR.0b013e3182a226bd","volume":"56","author":"J Doyen","year":"2013","unstructured":"Doyen J, Benezery K, Follana P et al (2013) Predictive factors for early and late local toxicities in anal cancer treated by radiotherapy in combination with or without chemotherapy. Dis Colon Rectum 56(10):1125\u20131133","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"3128_CR27","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.radonc.2009.07.006","volume":"93","author":"K Devisetty","year":"2009","unstructured":"Devisetty K, Mell LK, Salama JK et al (2009) A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapy. Radiother Oncol 93(2):298\u2013301","journal-title":"Radiother Oncol"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-026-03128-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-026-03128-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-026-03128-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:50:01Z","timestamp":1790355001000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-026-03128-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["3128"],"URL":"https:\/\/doi.org\/10.1007\/s10147-026-03128-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9309874\/v1","asserted-by":"object"}]},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"13 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"KH received lecture fee from Johnson and Johnson, Intuitive Surgical, Terumo Corporation, Olympus Corporation, and Medtronic.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethical committee of Japanese Society for Cancer of the Colon and Rectum and was conducted following the principles of the Declaration of Helsinki. The requirement for written informed consent was waived because of the retrospective nature of the study.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}